Joseph C. Papa
| Joseph C. Papa | |
|---|---|
| Born |
1955/1956 (age 60–61)[1] Connecticut |
| Residence | New Jersey |
| Nationality | American |
| Alma mater |
University of Connecticut Northwestern University |
| Salary | US$67.4 million |
| Title | Chairman and CEO, Valeant Pharmaceuticals |
| Term | May 2016- |
| Predecessor | J. Michael Pearson |
| Board member of | Valeant, Smith & Nephew |
Joseph C. Papa (born 1955/56) is an American businessman, the chairman and chief executive officer (CEO) of Valeant Pharmaceuticals from 2 May 2016, at an annual salary of US$67.4 million,[2] succeeding J. Michael Pearson.[3]
Early life
Papa received a bachelor's degree in Pharmacy from the University of Connecticut in 1978, and an MBA degree in Marketing and Finance from Northwestern University's Kellogg Graduate School of Management in 1983.[1][4]
Career
Prior to joining Valeant, Papa was the chairman and CEO of Perrigo, an American manufacturer of private label over-the-counter pharmaceuticals, from 2006 to 2016.[5] From December 2004 to October 2006, Papa was chairman and CEO of the pharmaceutical and technologies services of Cardinal Health, an Ohio health care services company. From 2001 to 2004, he was president and chief operating officer of Watson Pharmaceuticals, Inc. He has also worked at Novartis and Pharmacia/Searle, where he launched the medications Celebrex, Diovan, and Lotrel.[6]
References
- 1 2 Joseph C. Papa. "Joseph C. Papa: Executive Profile & Biography - Businessweek". Bloomberg.com. Retrieved 2016-04-29.
- ↑ Zachary Tracer. "Valeant Sets Incoming CEO Joe Papa's Pay at $67.4 Million". Bloomberg.com. Retrieved 2016-04-29.
- ↑ Steele, Anne (2016-04-25). "Valeant Names Joseph Papa as New CEO". WSJ. Retrieved 2016-04-29.
- ↑ "#161 Joseph C Papa". Forbes. Retrieved 10 May 2016.
- ↑ "Valeant new ceo pay package - Business Insider". Uk.businessinsider.com. 2016-03-31. Retrieved 2016-04-29.
- ↑ "Valeant Names Joseph C. Papa To Be Chairman And Chief Executive Officer Of Valeant Pharmaceuticals". ir.valeant.com/. Valeant Pharmaceuticals International, Inc. 25 April 2016. Retrieved 10 May 2016.